...
首页> 外文期刊>British Journal of Cancer >Pedunculated hepatocellular carcinoma and surgical treatment
【24h】

Pedunculated hepatocellular carcinoma and surgical treatment

机译:有蒂的肝细胞癌及手术治疗

获取原文

摘要

To determine the optimal surgical therapy for patients with pedunculated hepatocellular carcinoma (HC), we evaluated findings in ten patients with pedunculated HC among 350 patients with HC who underwent hepatectomy from 1975 to 1991 at Kyushu University Hospital. These patients were classified into three groups: Group I (n = 4) Pedunculated HC with no intrahepatic HC, Group II (n = 2) Pedunculated HC with a single intrahepatic HC, and Group III (n = 4) Pedunculated HC with multiple intrahepatic HC. Patients in group I and II were treated by partial hepatic resections or subsegmentectomies. In two patients there was an intrahepatic recurrence in the same lobe, after radical resection. All patients in group III who underwent palliative resection died within 8 months after surgery. Retrospectively, we favour the view that patients in Groups I or II may have had a better prognosis if lobectomy rather than partial hepatectomies had been done.
机译:为了确定有蒂肝细胞癌(HC)患者的最佳手术治疗方法,我们评估了九州大学医院从1975年至1991年接受肝切除的350例HC患者中10例有蒂肝癌的研究结果。这些患者分为三组:I组(n = 4)无肝内HC的带蒂HC,II组(n = 2)有单肝HC的有蒂HC,III组(n = 4)有多肝H的有蒂HC HC。 I组和II组的患者均接受部分肝切除或亚段切除术治疗。在两名患者中,根治性切除后同一叶肝内复发。第三组所有接受姑息性切除术的患者均在手术后8个月内死亡。回顾性地,我们赞成这样的观点,即如果进行了肺叶切除术而不是部分肝切除术,则第一或第二组患者的预后可能更好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号